Arthritis: all 3,555 studies

Page 5 of 36. Open to participants first (313), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT03823391Phase 2Results posted
• A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibTerminatedNCT03823378Phase 2Results posted
• Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT03813199Phase 2Results posted
• Psoriatic Oligoarthritis Intervention With Symptomatic thErapyCompletedNCT03797872Phase 4Results posted
• A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid ArthritisCompletedNCT03789292Phase 3Results posted
• A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic ArthritisCompletedNCT03783026Phase 4Results posted
• Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisTerminatedNCT03781375Phase 3Results posted
• Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)CompletedNCT03780959Phase 2/3Results posted
• Compression Nail for Tibiocalcaneal ArthrodesisCompletedNCT03780452Results posted
• A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic ArthritisCompletedNCT03773978Phase 3Results posted
• Impact of TheraWorx Foam on Symptom Relief in Thumb ArthritisCompletedNCT03770091Phase 3Results posted
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.CompletedNCT03747939Phase 4Results posted
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different ProcessesCompletedNCT03714022Phase 1Results posted
• Rheumatoid Arthritis Satisfaction Outcome ResearchCompletedNCT03703817Results posted
• Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid ArthritisCompletedNCT03691909Phase 1/2Results posted
• A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisCompletedNCT03682705Phase 2Results posted
• Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral ComponentCompletedNCT03681639Not applicableResults posted
• Comorbidities and Outcomes in Early Rheumatoid ArthritisCompletedNCT03675516Results posted
• Allofit® IT With HXPE in Total Hip ArthroplastyCompletedNCT03672929Results posted
• Allofit® IT Ceramic Bearing System in Total Hip ArthroplastyCompletedNCT03672916Results posted
• PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip ArthroplastyTerminatedNCT03672370Results posted
• Rheumatoid Arthritis Memory B Cells and AbataceptCompletedNCT03652961Phase 4Results posted
• COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RACompletedNCT03649061Phase 4Results posted
• Effects of Abatacept on Myocarditis in Rheumatoid ArthritisTerminatedNCT03619876Phase 4Results posted
• Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid ArthritisCompletedNCT03599986Results posted
• Persona TM Tibia Clinical Outcomes StudyCompletedNCT03589300Not applicableResults posted
• Skin to Adductor Canal Distance in Various PositionsCompletedNCT03562559Results posted
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.CompletedNCT03552276Phase 2/3Results posted
• Opioid-Free Shoulder ArthroplastyCompletedNCT03540030Phase 4Results posted
• Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanCompletedNCT03505008Phase 4Results posted
• Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic ArthritisCompletedNCT03486457Phase 3Results posted
• Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompletedNCT03449758Phase 4Results posted
• Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic FunctionCompletedNCT03417778Phase 1Results posted
• Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid ArthritisTerminatedNCT03410056Phase 1/2Results posted
• an On-demand Program to EmpoweR Active Self-management (OPERAS)CompletedNCT03404245Not applicableResults posted
• Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisCompletedNCT03387423Results posted
• Continuum™ Metal Bearing System in Total Hip ArthroplastyCompletedNCT03382652Results posted
• 3D MR Versus 3D CT for Glenohumeral ArthritisCompletedNCT03379545Not applicableResults posted
• Psoriatic Arthritis Research Collaborative: Biologic Sub-StudyCompletedNCT03378336Results posted
• Fascia Iliaca Blocks for Pain Control After Total Hip ArthroplastyCompletedNCT03375112Phase 4Results posted
• Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid ArthritisCompletedNCT03368235Phase 2Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic ArthritisCompletedNCT03347110Phase 2Results posted
• Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompletedNCT03334851Phase 1Results posted
• A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)CompletedNCT03311854Phase 2Results posted
• NexGen TM Tibia Clinical Outcomes StudyCompletedNCT03272373Not applicableResults posted
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisCompletedNCT03233230Phase 2Results posted
• The Effect of Review of a Decision Aid Prior to the Appointment on Decisional Conflict Compared to Usual Care in the Treatment of Trapeziometacarpal (TMC) ArthritisCompletedNCT03181724Not applicableResults posted
• Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RACompletedNCT03172325Phase 3Results posted
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)CompletedNCT03162796Phase 3Results posted
• Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid ArthritisCompletedNCT03156023Phase 1Results posted
• A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisCompletedNCT03151551Phase 4Results posted
• A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RACompletedNCT03147248Phase 3Results posted
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid ArthritisCompletedNCT03120949Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)CompletedNCT03104400Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugCompletedNCT03104374Phase 3Results posted
• A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDsCompletedNCT03086343Phase 3Results posted
• Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life ConditionsCompletedNCT03073109Results posted
• MSB11022 in Moderate to Severe Rheumatoid ArthritisCompletedNCT03052322Phase 3Results posted
• Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)CompletedNCT03031782Phase 3Results posted
• Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid ArthritisCompletedNCT03028467Phase 1/2Results posted
• Low Dose Naltrexone for Chronic Pain From ArthritisCompletedNCT03008590Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty ArthritisCompletedNCT03002974Phase 2Results posted
• A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha TherapyTerminatedNCT03001219Phase 2Results posted
• A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIACompletedNCT03000439Phase 3Results posted
• Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateCompletedNCT02996500Phase 2Results posted
• A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)CompletedNCT02990806Phase 3Results posted
• A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)CompletedNCT02986373Phase 2Results posted
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic ArthritisCompletedNCT02986139Phase 3Results posted
• The Effects of Hyperbaric Oxygen on Rheumatoid ArthritisCompletedNCT02984943Not applicableResults posted
• Korean Post-marketing Surveillance for XeljanzCompletedNCT02984020Results posted
• PyroTITAN Humeral Resurfacing Arthroplasty (HRA)CompletedNCT02983292Results posted
• A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350CompletedNCT02983227Phase 2Results posted
• Efficacy and Safety Study of SUNPG1623CompletedNCT02980692Phase 2Results posted
• A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisCompletedNCT02969525Phase 2Results posted
• Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To MethotrexateCompletedNCT02969044Phase 2Results posted
• Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid ArthritisTerminatedNCT02965599Phase 2Results posted
• A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to BiologicsCompletedNCT02960490Phase 2Results posted
• A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to MethotrexateCompletedNCT02960438Phase 2Results posted
• Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid ArthritisCompletedNCT02958319Results posted
• A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)CompletedNCT02955212Phase 3Results posted
• Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabCompletedNCT02937701Phase 3Results posted
• Standard Versus High Dose Inactivated Influenza Vaccine in RACompletedNCT02936180Phase 4Results posted
• Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTerminatedNCT02930343Phase 3Results posted
• National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisCompletedNCT02919761Phase 4Results posted
• Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid ArthritisCompletedNCT02919475Phase 2Results posted
• Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?TerminatedNCT02908490Phase 2Results posted
• Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedNCT02889796Phase 3Results posted
• Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX TherapyCompletedNCT02886728Phase 3Results posted
• Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With MethotrexateCompletedNCT02885181Phase 2Results posted
• Ticagrelor in Methotrexate-Resistant Rheumatoid ArthritisCompletedNCT02874092Phase 4Results posted
• Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) TreatmentCompletedNCT02873936Phase 3Results posted
• Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RACompletedNCT02865434Phase 1/2Results posted
• Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid ArthritisTerminatedNCT02862574Phase 2Results posted
• Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT02858492Phase 2Results posted
• Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)CompletedNCT02833350Phase 2Results posted
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisCompletedNCT02831855Phase 4Results posted
• PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid ArthritisCompletedNCT02819726Phase 1Results posted

← Arthritis overview